0001415889-23-015310.txt : 20231120
0001415889-23-015310.hdr.sgml : 20231120
20231120181013
ACCESSION NUMBER: 0001415889-23-015310
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stefanelli Jill
CENTRAL INDEX KEY: 0001980919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 231423911
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
form4-11202023_111107.xml
X0508
4
2023-11-16
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001980919
Stefanelli Jill
4995 BRADENTON AVE
SUITE 240
DUBLIN
OH
43017
true
false
false
false
0
Common Stock
2023-11-16
4
A
0
275000
0
A
525000
D
Common Stock
2023-11-16
4
A
0
416667
0
A
941667
D
Shares vest upon the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.
Shares vest in three equal tranches, with the first tranche vesting on June 1, 2024 (the "Initial Vesting Date"), with the remaining tranches vesting ratably annually from the Initial Vesting Date over the following two years, subject to the Reporting Person's continuous service to the Company.
Gioia Gentile on behalf of Jill Stefanelli by power of attorney
2023-11-20